Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS ...

Global poultry vaccine market is observing significant growth owing to the rising prevalence of poultry diseases. The report runs an in-dept ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

In 2024 and 2025, Gartner projects spending on data center systems to grow faster than overall IT spending. More specifically ...

Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.

Sydney Towle is sharing her cancer journey on social media as a way to connect with and help others. She's currently waiting ...

About Biora Therapeutics Biora Therapeutics is a clinical-stage biotech company developing two smart pill-based therapeutics platforms: the NaviCap™ platform for colon-targeted treatment of IBD, ...

Shares of Norfolk Southern Corp. NSC inched 0.35% higher to $271.67 Friday, on what proved to be an all-around favorable ...

In the first half of 2025, Werewolf expects to provide an update on the WTX-124 clinical development program, including data ...

Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...

Department of Pediatric Traditional Chinese Medicine Clinic, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangdong, China Coronary artery lesions are the most severe ...